- Protocol
- Open access
- Published:
Reliability of the evidence to guide decision-making in the treatment of gastroesophageal reflux disease with acupuncture: protocol for an overview of systematic reviews
Systematic Reviews volume 13, Article number: 183 (2024)
Abstract
Background
Growing numbers of randomized clinical trials-based systematic reviews and meta-analyses (SRs/MAs) have been conducted to examine the effectiveness of acupuncture in treating gastroesophageal reflux disease (GERD). An overview of SRs/MAs will be conducted with the aim of systematically compiling, evaluating, and synthesizing the evidence regarding acupuncture for GERD.
Methods
SRs/MAs of acupuncture on GERD will be searched in eight databases. Two independent reviewers will conduct the literature search, data extraction, and review quality assessment. Utilizing the AMSTAR-2 tool, PRISMA checklists, and GRADE system, respectively, the methodological quality, reporting quality, and evidence quality will be evaluated. In relation to the subject and the overview’s objects, the results will be given. This study will aid in identifying gaps between evidence and its clinical application and serve as a roadmap for further high-quality research.
Discussion
The results of the overview will aid in closing the gap between clinical evidence and its use in clinical practice. This study will identify significant faults in the use of evidence, point out areas where methodology needs to be improved, and provide guidance for future high-quality research.
Systematic review registration
PROSPERO CRD42022371850.
Ethics and dissemination
Ethics approval is not necessary because no personal information about individuals is collected. A peer-reviewed journal or pertinent conferences will publish the results, whichever comes first.
Background
Gastroesophageal reflux disease (GERD) is a chronic digestive disorder characterized by heartburn and regurgitation brought on by gastroesophageal reflux [1]. The chronic and highly prevalent nature of GERD confers a significant socioeconomic burden worldwide, with approximately 20% of the population in Western countries [2] affected and 5–18% of the population in Asian countries [3]. The expenditures due to GERD are enormous, amounting to $15–20 billion in the USA alone in 2006, with the major expenditures on therapeutic agents [4]. Current treatment strategies for GERD aim to alleviate or reduce gastric acid secretion, and commonly used medications include proton pump inhibitors, antacids, and histamine receptor antagonists [5]. However, the effectiveness of the available medicinal therapies varies greatly, and the majority of people need to take medication for an extended period of time or perhaps for the rest of their lives [6]. In addition, drug resistance has been observed in some patients, who in some cases have been forced to undergo surgical intervention [7]. Therefore, a better understanding of the evidence for the treatment of GERD with complementary and alternative therapies and assessment of their applicability to the management of GERD are currently urgent issues to be addressed.
Acupuncture has been used to treat gastrointestinal disorders such as GERD, and evidence on this topic is emerging. Not all systematic reviews (SRs)/meta-analyses (MAs), however, can offer trustworthy evidence, and the clinical decision-making process may be misled by poor-quality evidence [8]. Additionally, measurement tools like AMSTAR-2 [9], PRISMA [10], and GRADE system [11] were introduced in 2007, 2009, and 2004 correspondingly to assure the standardization of evidence sources.
An overview of SRs/MAs will be required with the aim of systematically compiling, evaluating, and synthesizing the evidence when several of SRs/MAs are published for related issues in a short period of time.
Methods
Patient and public involvement
The public and the patients will not be involved.
Registration and protocol
The PROSPERO database has this protocol listed as registered (CRD42022371850). We will report the review in the detail mandated by the PRISMA checklists [10].
Review eligibility criteria
Studies of a certain type
Randomized clinical trials examining the effects of acupuncture for GERD were enrolled by SRs/MAs. Network meta-analyses will not be included.
Types of participants
Regardless of sex, age, race, or illness course, participants are given a diagnosis of GERD in accordance with the internationally recognized criteria for diagnosis.
Types of interventions
Patients with GERD in the experimental group will receive acupuncture alone or acupuncture plus conventional medication, while patients with GERD in the control group will receive sham acupuncture or conventional medication alone.
Types of outcomes
Global symptom improvement will be evaluated as the primary outcome. Symptom score, quality of life, recurrence rate, and adverse events will be evaluated as the secondary outcomes.
Search strategy
We will report search strategies in the detail mandated by the PRISMA-S extension [12]. PubMed, Web of Science, Embase, Cochrane Library, China National Knowledge Infrastructure, VIP, SinoMed, and Wanfang will be searched from their inception to August 2023. In order to locate pertinent studies, references to systematic reviews on this subject will also be checked. The specific search strategy is modified according to different databases. Table 1 provides the search strategy for the PubMed database.
Evaluation of eligibility and extraction of data
By two independent reviewers, the literature will be screened (Fig. 1). A knowledgeable third reviewer will arbitrate any disagreements.
By two independent reviewers, the data from the included studies will be extracted. The initial author, publication year, nation, the number of trials that were enrolled, techniques for quality assessment, interventions, and comparisons, as well as the primary outcomes and data synthesis techniques, will be extracted. A knowledgeable third reviewer will arbitrate any disagreements.
Quality assessment
Two independent reviewers will evaluate the methodological quality of the included reviews using the AMSTAR-2 instrument [9]. In addition, PRISMA checklists [10] will be used to evaluate the reporting quality of the included SRs/MAs. The quality of the evidence will be evaluated using the GRADE system [11] as a final step. For certainty of evidence, if the authors of the included studies have implemented an evaluation of the quality of the evidence, we will still prioritize the use of the results of our evaluations to ensure a consistent process of evaluating the certainty of the evidence across all included studies. A knowledgeable third reviewer will arbitrate any disagreements.
Data synthesis
It will be done in an overview with a descriptive analysis [13]. Data from individual trials may have been pooled more than once in SRs/MAs included in the overview; as a result, this study will not undertake a meta-analysis. Results from the included reviews will be presented as weighted mean differences or standard mean differences with 95% confidence intervals for continuous data and as risk ratios or odds ratios for dichotomous data. Both tabular and graphical representations of the quality assessment’s findings will be provided.
Discussion
Acupuncture has long been used clinically to treat GERD in China. In spite of this, the researchers are adamant that this treatment has not yet reached its full potential in an actual-life setting. The application of acupuncture in real-world dynamics differs from its evidence-based clinical application.
The evidence gained from SRs/MAs, which are thought of as the gold standard for evaluating the effectiveness of clinical interventions, is currently facing difficulties because of the numerous risks of bias that are created during the development of evidence [14]. Low-quality evidence may mislead decision-makers, whereas high-quality SRs/MAs can give trustworthy evidence [8]. Therefore, the veracity of the evidence and its practical implementation are not always congruent. Evidence from SRs/MAs regarding acupuncture for GERD has emerged in recent years. Nevertheless, their outcomes are inconsistent and of variable quality. The creation of clinical protocols and healthcare judgments are all jeopardized by these problems. An overview of SRs/MAs in this field is required in light of the current situation. This review’s ultimate objective is to give a full assessment of existing evidence on a variety of similar topics, to give evidence users with more targeted and superior information, and to uncover fundamental problems in evidence use [15]. The comprehensive research design for conducting an overview on the treatment of GERD with acupuncture is described in this protocol. By making this protocol public, we can assure that its overview may be reproduced by others and gain insight from the comments of subject matter experts. However, limitations of this study need to be acknowledged as MEDLINE (Medical Literature Database Series) will not be accessible, which may lead to bias.
References
Fass R. Gastroesophageal reflux disease. N Engl J Med. 2022;387(13):1207–16. https://doiorg.publicaciones.saludcastillayleon.es/10.1056/NEJMcp2114026. (PMID: 36170502).
Dent J, El-Serag HB, Wallander M-A, Johansson S. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2005;54:710–7.
Jung HK. Epidemiology of gastroesophageal reflux disease in Asia: a systematic review. J Neurogastroenterol Motil. 2011;17:14–27.
Gawron AJ, French DD, Pandolfino JE, Howden CW. Economic evaluations of gastroesophageal reflux disease medical management. Pharmacoeconomics. 2014;32:745–58.
Iwakiri K, Fujiwara Y, Manabe N, Ihara E, Kuribayashi S, Akiyama J, Kondo T, Yamashita H, Ishimura N, Kitasako Y, Iijima K, Koike T, Omura N, Nomura T, Kawamura O, Ohara S, Ozawa S, Kinoshita Y, Mochida S, Enomoto N, Shimosegawa T, Koike K. Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2021. J Gastroenterol. 2022;57(4):267–85.
Chen J, Brady P. Gastroesophageal reflux disease: pathophysiology, diagnosis, and treatment. Gastroenterol Nurs. 2019;42(1):20–8.
Badillo R, Francis D. Diagnosis and treatment of gastroesophageal reflux disease. World J Gastrointest Pharmacol Ther. 2014;5:105–12.
Huang J, Wu M, Liang S, et al. A critical overview of systematic reviews and meta-analyses on acupuncture for poststroke insomnia. Evid Based Complement Alternat Med. 2020;9(2020):2032575.
Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, Moher D, Tugwell P, Welch V, Kristjansson E, Henry DA. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358:j4008. https://doiorg.publicaciones.saludcastillayleon.es/10.1136/bmj.j4008.
Moher D, Liberati A, Tetzlaff J, Altman D. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.
Pollock A, Farmer SE, Brady MC, Langhorne P, Mead GE, Mehrholz J, van Wijck F, Wiffen PJ. An algorithm was developed to assign GRADE levels of evidence to comparisons within systematic reviews. J Clin Epidemiol. 2016;70:106–10.
Rethlefsen ML, Kirtley S, Waffenschmidt S, Ayala AP, Moher D, Page MJ, Koffel JB, PRISMA-S Group. PRISMA-S: an extension to the PRISMA statement for reporting literature searches in systematic reviews. Syst Rev. 2021;10(1):39.
Bougioukas KI, Vounzoulaki E, Mantsiou CD, et al. Methods for depicting overlap in overviews of systematic reviews: an introduction to static tabular and graphical displays. J Clin Epidemiol. 2021;132:34–45.
Huang Jinke Wu, Manli LS, et al. A critical overview of systematic reviews and meta-analyses on acupuncture for poststroke insomnia. Evid Based Complement Alternat Med. 2020;2020:2032575.
Hunt H, Pollock A, Campbell P, et al. An introduction to overviews of reviews: planning a relevant research question and objective for an overview. Syst Rev. 2018;7:39.
Funding
This work was supported by Spleen and Stomach Disease Inheritance and Innovation Team of Science and Technology Innovation Project of China Academy of Chinese Medical Sciences (No. CI2021B005).
Spleen and Stomach Disease Inheritance and Innovation Team of Science and Technology Innovation Project of China Academy of Chinese Medical Sciences,CI2021B005,Xudong Tang
Author information
Authors and Affiliations
Contributions
Conceptualization: Jinke Huang. Methodology: Jinke Huang, Jiali Liu. Supervision: Fengyun Wang and Xudong Tang. Validation: Xudong Tang. Writing—original draft: Jinke Huang. Writing—review and editing: Jinke Huang and Xudong Tang.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
Not applicable.
Competing interests
No conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Huang, J., Liu, J., Wang, F. et al. Reliability of the evidence to guide decision-making in the treatment of gastroesophageal reflux disease with acupuncture: protocol for an overview of systematic reviews. Syst Rev 13, 183 (2024). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13643-024-02591-4
Received:
Accepted:
Published:
DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13643-024-02591-4